Cancer screening rates lower among those with fatalistic attitudes

September 27, 2011, American Association for Cancer Research

Even if health care is free, colorectal cancer screening rates among those without financial means are still low, and results of a new study suggest that may be due to an idea psychologists call cancer fatalism.

Anne Miles, Ph.D., a lecturer in psychology at Birkbeck, University of London, said those who felt that the cancer screenings wouldn't help, or they were going to die of cancer anyway, often failed to comply with screening recommendations.

Her findings are published in a recent issue of , Biomarkers & Prevention, a journal of the American Association for Cancer Research.

"In England, the screenings are free and the subsequent health treatments are free as well, yet people of lower socioeconomic status still do not get screened. We wanted to find out what else was going on," she said.

Miles and her colleagues analyzed data from 529 adults aged 60 to 69 who had completed a series of surveys measuring their socioeconomic status, self-rated health and rate of cancer fatalism. These measures were tested against the rate of fecal occult blood testing.

They found that men and women with higher socioeconomic status, better self-rated health and lower cancer fatalism were 56 percent more likely to undergo by fecal occult blood testing.

Miles said cancer can be reduced if properly identified.

"There is clearly something else going on here besides costs. We need to understand peoples' attitudes toward screening," said Miles. "If they think it won't help, they won't do it, even if it's free."

Explore further: Colorectal cancer screening rates on rise among Medicare beneficiaries due to expansion of coverage

Related Stories

Colorectal cancer screening rates on rise among Medicare beneficiaries due to expansion of coverage

May 3, 2011
Colorectal cancer screening rates increased for Medicare beneficiaries when coverage was expanded to average-risk individuals, but racial disparities still exist, according to researchers at The University of Texas Health ...

Recommended for you

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.